Cypriot biotech company Theramir, which is focused on the development of innovative targeted cancer therapeutics and diagnostics, announced today the closing of its latest funding round that welcomed two new strategic investors, ASBISc Enterprises Plc and the Lanitis Group. The new investment will enable Theramir to advance the development of…Read More
Cypriot company receives major investment to develop microRNA therapeutics
